Navigation Links
Natalie Douglas, CEO of Idis, Joins Global Genes | RARE Project Board of Directors

ALISO VIEJO, Calif. and PRINCETON, N.J., Feb. 12, 2013 /PRNewswire/ -- Global Genes | RARE Project and Idis are pleased to announce the addition of Natalie Douglas , CEO of Idis, to the Global Genes | RARE Project Board of Directors.  

Throughout her career and now as CEO of Idis, Douglas has pursued the cause for providing access to medicines for patients with unmet medical needs.   Her experience in the pharmaceutical industry introduced her to the therapeutic challenges for physicians in managing the unmet medical needs of patients including those with cancer and AIDS.

As an organization, Idis reflects the deep commitment and compassion embodied by Douglas for patients in the rare disease community.   In 2012 alone, Idis helped more than 720,000 patients, including many with rare diseases, gain access to critical therapies.  The results-driven mindset of the organization has helped patients gain access even in the most challenging situations.

Recognizing the complex nature of addressing unmet medical needs, Douglas is a passionate advocate for creating more meaningful, productive connections between industry, regulatory authorities, and the patient advocacy community to identify and remove barriers to access. 

"We are honored to have Natalie join our Board of Directors; her passion and commitment to rare disease and its community is more than evident in all she does both personally and professionally.  She will bring tremendous value and insights to the organization as it works to create a larger impact globally," stated Nicole Boice , Founder/President Global Genes | RARE Project.

"Addressing the unmet medical needs in the rare disease community is especially challenging," noted Douglas.  "The Global Genes | RARE Project has created a much needed voice for these patients and their families.  I am delighted to join the board of an organization that has made such an impact for an underserved population and look forward to contributing to their important mission." 

The addition of Ms. Douglas to the Board of Directors will be the first of many announcements this year from Global Genes | RARE Project, as the organization works to secure additional board members that bring important expertise to this growing organization.

"Our organization is entering an important period of growth, expectations have increased, and Global Genes | RARE Project wants to ensure that it continues to deliver increased value to those whom we serve - the rare disease patient advocacy community," stated Boice.   

About Global Genes | RARE Project
Global Genes | RARE Project is a leading global rare and genetic disease patient advocacy organization.  Global Genes | RARE Project works to build and unify a global rare and genetic disease community and positively impact patients in their lifetime by offering programs designed to educate, empower, and support patients, advocates, foundations, and other rare disease focused organizations. 

About Idis
Idis has 25 years experience of partnering with pharmaceutical and biotechnology companies to create regulatory-compliant, ethical access to medicines for healthcare professionals and their patients with unmet medical needs. Since 1987, Idis has developed and managed access to thousands of medicines from every therapeutic category, impacting the lives of hundreds of thousands of patients in countries around the world.  Idis leverages decades of experience, regulatory insight, and a thorough understanding of local and global requirements to create access to medicines at every stage of a product's lifecycle from pre-approval to market exit, and in times of unexpected production shortages.  The company's international headquarters are located in Weybridge, United Kingdom, and North American headquarters are located in Princeton, NJ. For more information, visit

Global Genes | RARE Project
Carrie Ostrea
Phone: 949-248-7273

Christine Quern
Feinstein Kean Healthcare
Phone: 617-761-6791

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Natalie Douglas, CEO von Idis, tritt Vorstand von Global Genes
2. RARE Project bei
3. Breast Imaging Specialist Dr. Catherine D. Buhler Joins Radiologic Associates of Fredericksburg
4. Stephen Ondra, M.D., Joins Health Care Service Corporation As Enterprise Chief Medical Officer
5. Attorney Ellen Presby Joins The Nemeroff Law Firm In Dallas
6. Kevin Johnson Joins United Allergy Services Board Of Directors
7. Robert Funari Joins NxStage Board of Directors
8. B. Braun Joins National Health Organization Supporting Environmental Practices
9. University of Pennsylvania joins Actinium Pharmaceuticals Multicenter Actimab-A Trial
10. Kerry R. Hicks Joins Physicians Capital Investments as Vice-Chairman of Board
11. Dr. Peter Diamandis Joins Tribogenics Advisory Board
Post Your Comments:
(Date:10/7/2017)... Texas , Oct. 6, 2017   Provista, ... with more than $100 billion in purchasing power, today ... news and information. The Newsroom is the ... and industry trends, infographics, expert bios, news releases, slideshows ... having access to a wealth of resources at their ...
(Date:10/4/2017)... -- According to the Centers for Disease Control and Prevention (CDC), influenza ... Care is helping communities across Massachusetts , ... no-cost* flu shots through the end of the month. *Some ... ... flu shot is by the end of October, according to the Centers ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work ... as “patient engagement.” The patient is doing more than filling out a survey; in ... “There is an increasing emphasis in health care and research on the importance of ...
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
Breaking Medicine News(10 mins):